NEWPORT BEACH, Calif.–(BUSINESS WIRE)–CureDuchenne today applauded the U.S. Food and Drug Administration (FDA), which took the critical step of accepting the first-ever New Drug Application (NDA) for a possible treatment […]
Featured Posts
Results from an extensive new study suggest that early symptoms of Alzheimer’s disease appear up to 18 years before the disease is officially diagnosed. Researchers publishing in the journal Neurology […]
External models of R&D innovation are the rage in Pharma today, as they should be – the future of our industry depends on a great deal more rather than less […]
National Institutes of Health (NIH) researchers want to study the biology of human placenta to better understand its role in pregnancy. But, studying the human placenta has challenges. Because the placenta […]
Provides identification of potential patient safety issues and actionable insight into clinical trial site performance RESEARCH TRIANGLE PARK, N.C. – June 15, 2015 – Quintiles, the world’s largest biopharmaceutical services […]
Easy-to-use, fingertip access to essential clinical trial insights RESEARCH TRIANGLE PARK, N.C. – June 16, 2015 – Quintiles, the world’s largest biopharmaceutical services company, is extending its award-winning Quintiles […]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced important next steps in the evolution of the company’s R&D organization, including plans to expand its presence within hubs of scientific excellence […]
Immunovaccine and Incyte to Co-Fund Clinical Trial Combining DPX-Survivac and Epacadostat for Patients with Recurrent Disease HALIFAX, NOVA SCOTIA–(Marketwired – June 25, 2015) – Immunovaccine Inc. (“Immunovaccine” or the “Company”) […]
Data Presented at the International Congress of Parkinson’s Disease and Movement Disorders APL-130277, Sublingual Apomorphine, for On-Demand Treatment of OFF Episodes Associated with Parkinson’s Disease TORONTO, ONTARIO–(Marketwired – June 25, […]
Two brothers – one an entrepreneur, the other a Columbia University psychiatrist – are claiming today that a new combination of experimental medicines may prevent suicidal thoughts in people with […]